The preliminary analysis of SUSARs from the PvPI database reveals that the following drugs are associated with the risks as given below.
Table
|
S.No |
Suspected Drugs |
Indication |
Adverse Reactions |
|
1 |
Peginterferon alpha-2a |
Chronic active Hepatitis B & C |
Vasculitis |
|
2 |
Piperacillin & Tazobacam |
In the treatment of lower RTI/UTI/intra abdominal infections, skin and skin structure infections, bacterial septicaemia polymicrobic infection |
Vision abnormal |
|
3 |
Mometasone Furoate, Topical |
Steroid responsive dermatitis , eczema, or atopic dermatitis |
Hypertrichosis/Hirsutism, Skin depigmentation |
Health care professionals, Patients/Consumers are advised to closely monitor the possibility of the above adverse events while prescribing/consuming above suspected drugs and report to the NCC-PvPI either by filling of Suspected Adverse Drug Reactions Reporting Form/
Medicines Side Effect Reporting Form for Consumer (https://www.ipc.gov.in) or by PvPI Helpline No. 1800-180-3024.